# BYNFEZIA Pen

NDC: 62756-452
Generic name: octreotide acetate
Labeler / Manufacturer: Sun Pharmaceutical Industries, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20250224

FDA application: NDA213224

## Active ingredients

- OCTREOTIDE ACETATE: 2.5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62756-452"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62756-452
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=20ed4e79-ad4c-426f-859d-83790c00439b